123 results on '"adoptive cell therapy"'
Search Results
2. Recent advancements in improving the efficacy and safety of chimeric antigen receptor (CAR)-T cell therapy for hepatocellular carcinoma
3. Recent Advances in Immunotherapy for Advanced Biliary Tract Cancer
4. Immunological Checkpoint Blockade in Anal Squamous Cell Carcinoma: Dramatic Responses Tempered By Frequent Resistance
5. Beyond Immune Checkpoint Inhibitors: Emerging Targets in Melanoma Therapy
6. Recent clinical researches and technological development in TIL therapy
7. A “Prime and Expand” strategy using the multifunctional fusion proteins to generate memory-like NK cells for cell therapy
8. Cryo-thermal therapy reshaped the tumor immune microenvironment to enhance the efficacy of adoptive T cell therapy
9. Nanotechnology for boosting ovarian cancer immunotherapy
10. Outcome of Pneumocystis Jirovecii pneumonia (PcP) in post-CAR-T patients with hematological malignancies
11. Establishment of a protocol for rapidly expanding Epstein–Barr-virus-specific cytotoxic T cells with enhanced cytotoxicity
12. Disrupting Smad3 potentiates immunostimulatory function of NK cells against lung carcinoma by promoting GM-CSF production
13. Current and future immunotherapeutic approaches in pancreatic cancer treatment
14. CAR T cells outperform CAR NK cells in CAR-mediated effector functions in head-to-head comparison
15. The potential and promise for clinical application of adoptive T cell therapy in cancer
16. Immunosuppressive tumor microenvironment and immunotherapy of hepatocellular carcinoma: current status and prospectives
17. Functional CRISPR screens in T cells reveal new opportunities for cancer immunotherapies
18. Harnessing adenovirus in cancer immunotherapy: evoking cellular immunity and targeting delivery in cell-specific manner
19. CD4+CD25+ regulatory T cells ex vivo generated from autologous naïve CD4+ T cells suppress EAE progression
20. Enhanced tumor control activities of anti-mPD-L1 antibody and antigen-presenting cell-like natural killer cell in an allograft model
21. Genetic engineering of regulatory T cells for treatment of autoimmune disorders including type 1 diabetes
22. Chimeric Antigen Receptor (CAR)-Based Cell Therapy for Type 1 Diabetes Mellitus (T1DM); Current Progress and Future Approaches
23. Incorporating IL7 receptor alpha signaling in the endodomain of B7H3-targeting chimeric antigen receptor T cells mediates antitumor activity in glioblastoma
24. Breast cancer immunotherapy: a comprehensive review
25. Targeting CDH17 with Chimeric Antigen Receptor-Redirected T Cells in Small Cell Lung Cancer
26. CD4−/CD8− double-negative tumor-infiltrating lymphocytes expanded from solid tumor tissue suppress the proliferation of tumor cells in an MHC-independent way
27. The CAR macrophage cells, a novel generation of chimeric antigen-based approach against solid tumors
28. Challenges and new technologies in adoptive cell therapy
29. CRISPR/Cas9 system: recent applications in immuno-oncology and cancer immunotherapy
30. RAS signaling and immune cells: a sinister crosstalk in the tumor microenvironment
31. Eosinophils in the tumor microenvironment: implications for cancer immunotherapy
32. Adoptive neoantigen-reactive T cell therapy: improvement strategies and current clinical researches
33. Adoptive cellular immunotherapy for solid neoplasms beyond CAR-T
34. The “Great Debate” at Immunotherapy Bridge 2022, Naples, November 30th–December 1st, 2022
35. Antitumor effect of neoantigen-reactive T cells combined with PD1 inhibitor therapy in mouse lung cancer
36. Successful ex vivo expansion of tumor infiltrating lymphocytes with systemic chemotherapy prior to surgical resection
37. Using patient-derived tumor organoids from common epithelial cancers to analyze personalized T-cell responses to neoantigens
38. Recombinant Human Cyclophilin A in Combination with Adoptive T-cell Therapy Improves the Efficacy of Cancer Immunotherapy in Experimental Models in vivo
39. Involving stemness factors to improve CAR T-cell-based cancer immunotherapy
40. CAR T cells redirected against tumor-specific antigen glycoforms: can low-sugar antigens guarantee a sweet success?
41. Immunotherapy and Biomarkers in Sarcoma
42. Revamping the innate or innate-like immune cell-based therapy for hepatocellular carcinoma: new mechanistic insights and advanced opportunities
43. NK cells and solid tumors: therapeutic potential and persisting obstacles
44. Computational analysis of 4-1BB-induced NFκB signaling suggests improvements to CAR cell design
45. Dual-binding nanoparticles improve the killing effect of T cells on solid tumor
46. Nanobody-based CAR-T cells for cancer immunotherapy
47. In Vitro Generation of BK polyomavirus-specific T cells for adoptive cell therapy in refractory cystitis hemorrhagic patients after hematopoietic stem cell transplantation
48. Natural killer cells in clinical development as non-engineered, engineered, and combination therapies
49. Longitudinal single-cell analysis of a patient receiving adoptive cell therapy reveals potential mechanisms of treatment failure
50. Chimeric antigen receptor (CAR) immunotherapy: basic principles, current advances, and future prospects in neuro-oncology
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.